MNPR · Monopar Therapeutics · Documents

$71.42 +4.20 (+6.25%) At close · Nov 6

Russell 2000 member Rebalance outlook locked

Market Cap

$479.38M

6.71M

Volume · Nov 6 94.21K Avg daily vol (3M) 164.19K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $0 10-K filed Mar 27, 2026 Quarterly report FY2026 Q2 Net loss $5.31M 10-Q filed Aug 12, 2026 Latest results Financial results 8-K filed Aug 12, 2026

2026

Aug 12

Current report 8-K

Financial results AI summary on its way

Aug 12

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Net loss $5.31M

Jul 22

Current report 8-K

Regulation FD disclosure AI summary on its way

Jun 30

Current report 8-K

Regulation FD disclosure AI summary on its way

Jun 26

Current report 8-K

Regulation FD disclosure AI summary on its way

Jun 23

Current report 8-K Events of Jun 22

Shareholder vote results AI summary on its way

May 29

Current report 8-K

Regulation FD disclosure AI summary on its way

May 19

Current report 8-K

Regulation FD disclosure AI summary on its way

May 14

Current report 8-K

Financial results AI summary on its way

May 14

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Revenue $0 Net loss $3.89M

Apr 30

Proxy statement DEF 14A Meeting Jun 22, 2026

Proxy statement AI summary on its way

Apr 30

Annual report to holders ARS

Annual report to holders AI summary on its way

Apr 30

Proxy statement DEFA14A

Proxy statement AI summary on its way

Apr 20

Current report 8-K Events of Apr 19

Regulation FD disclosure AI summary on its way

Apr 1

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2025 AI summary on its way

Mar 27

Current report 8-K

Financial results AI summary on its way

Mar 27

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $0 Net loss $13.72M

Mar 2

Current report 8-K

Regulation FD disclosure AI summary on its way

2025

Nov 13

Current report 8-K

Financial results

Nov 13

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Net loss $3.44M

Nov 10

Current report 8-K Events of Nov 9

Regulation FD disclosure

Sep 24

Current report 8-K Events of Sep 23

Entered into a material agreement, Regulation FD disclosure

Sep 15

Current report 8-K

Regulation FD disclosure

Aug 29

Registration statement S-3

Registration statement

Aug 12

Current report 8-K

Financial results

Aug 12

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Net loss $2.45M

Jun 23

Current report 8-K Events of Jun 17

Shareholder vote results

May 23

Proxy statement DEFA14A

Proxy statement

May 13

Current report 8-K

Financial results

May 13

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Net loss $2.62M

May 12

Annual report to holders ARS

Annual report to holders

May 7

Current report 8-K

Regulation FD disclosure

Apr 30

Proxy statement DEF 14A Meeting Jun 17, 2025

Proxy statement

Mar 31

Current report 8-K

Financial results

Mar 31

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $0 Net loss $15.59M

Mar 3

Current report 8-K Events of Feb 27

Director or officer change, or executive pay

Feb 24

Current report 8-K Events of Feb 19

Director or officer change, or executive pay

Jan 15

Registration statement S-3

Registration statement

2024

Dec 23

Current report 8-K Events of Dec 20

Entered into a material agreement, Unregistered sale of equity

Dec 6

Current report 8-K

Regulation FD disclosure

Nov 29

Registration statement S-3

Registration statement

Nov 8

Current report 8-K

Financial results

Nov 8

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Net loss $1.3M

Oct 30

Current report 8-K Events of Oct 28

Entered into a material agreement, Regulation FD disclosure

Oct 24

Current report 8-K Events of Oct 23

Entered into a material agreement, Completed an acquisition or sale of assets, New debt or off-balance-sheet obligation, Unregistered sale of equity, Regulation FD disclosure, Other events

Oct 22

Current report 8-K

Regulation FD disclosure

Oct 15

Current report 8-K

Regulation FD disclosure

Oct 7

Current report 8-K

Regulation FD disclosure

Sep 12

Current report 8-K

Regulation FD disclosure

Aug 27

Current report 8-K

Regulation FD disclosure

Showing 1–50 of 166 documents

Key facts CIK 1645469 CUSIP 61023L207 13F (30d) 28 filings 24 filers Visit website Investor relations